Trial site
CHRU - Hôpital Bretonneau
- 2running trials
- 1closed trial
- 0trials confirmed by the site in the last 60 days
- –languages not stated
No trial has been confirmed here yet.
Running trials
Active, not recruiting
Use of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma
Active, not recruiting
A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Researchers
No researcher is linked here yet.
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026